Jørgen Søberg Petersen

Direktørposter 1 Se alle › Bestyrelsesposter 5 Se alle › Selskaber 0 Se alle ›

Oversigt

Om Jørgen Søberg Petersen

Jørgen Søberg Petersen startede sin erhvervskarriere i ZEALAND PHARMA A/S tilbage i 2006. I dag er Jørgen aktiv i 6 virksomheder.

Ud fra vores kendskab har Jørgen 55 netværksforbindelser gennem sit ejerskab af virksomheder, bestyrelsesposter m.m.

Karriere start

ZEALAND PHARMA A/S › Direktør

Største overskud

535’ DKK BLUE Healthcare Investments ApS › 2016

Laveste overskud

-156.407’ DKK Hemab ApS › 2022

Største egenkapital

136.196’ USD Hemab ApS › 2023

Største gæld

40.988’ ACESION PHARMA ApS › 2020

Direktørposter

RheumaLogics ApS

Direktør

Siden 2024-12-05

Ansatte 1

Datterselskaber 0

Resultat før skat -

Forbindelser

Nik Economopoulos

Via ACESION PHARMA ApS ›

Timothy Michael Shannon

Via ACESION PHARMA ApS ›

Benjamin Bruno Thorner

Via ACESION PHARMA ApS ›

Anders Gaarsdal Holst

Via ACESION PHARMA ApS ›

Ulrik Svane Sørensen

Via ACESION PHARMA ApS ›

Morten Grunnet

Via ACESION PHARMA ApS ›

Canaan XII L.P.

Via ACESION PHARMA ApS ›

Alpha Wave Ventures II, LP

Via ACESION PHARMA ApS ›

Christopher Ashby Voigt

Via:

FC Inbio Holdings Limited

Via ACESION PHARMA ApS ›

Ole Jakob Müller

Via:

Nana Sejbæk

Via:

Liselotte Højgaard

Via:

Lars Henrik Fugger

Via:

Stig Strøbæk

Via:

Mads Boritz Grøn

Via:

Lars Rebien Sørensen

Via:

Lars Henrik Munch

Via:

Steen Riisgaard

Via:

Philip Just Larsen

Via Antag Therapeutics ApS ›

Mark Currie

Via Antag Therapeutics ApS ›

Alexander Volker Wilhelm Mayweg

Via Antag Therapeutics ApS ›

Amit Kantilal Shah

Via Antag Therapeutics ApS ›

Jörg Möller

Via Antag Therapeutics ApS ›

Mette Marie Rosenkilde

Via Antag Therapeutics ApS ›

Maria Buur Nordskov Gabe

Via Antag Therapeutics ApS ›

Jens Juul Holst

Via Antag Therapeutics ApS ›

Dawn Holdco SCSp

Via Antag Therapeutics ApS ›

Versant Venture Capital VII, L.P.

Via Antag Therapeutics ApS ›

SR One Capital Fund II Aggregator, LP

Via Antag Therapeutics ApS ›

Broadview Ventures I LLC

Via Antag Therapeutics ApS ›

Ulrik Mouritzen

Via Breye Therapeutics ApS ›

Chiara Rossana Maria Liberati

Via Breye Therapeutics ApS ›

Carl Johan Kördel

Via Breye Therapeutics ApS ›

Gabriela Burian

Via Breye Therapeutics ApS ›

Jimmy Arnold V Van Heusden

Via Breye Therapeutics ApS ›

Golgi NueroSciences S.R.L.

Via Breye Therapeutics ApS ›

Sound Bioventures Fund I AB

Via Breye Therapeutics ApS ›

Benny Sørensen

Via Hemab ApS ›

Mårten Steen

Via Hemab ApS ›

Laura Anne Tadvalkar

Via Hemab ApS ›

Linda Catharina Bain

Via Hemab ApS ›

Uya Chuluunbaatar

Via Hemab ApS ›

Daniel Becker

Via Hemab ApS ›

Akshay Krishnadas Vaishnaw

Via Hemab ApS ›

Mads Nikolaj Behrndt-Eriksen

Via Hemab ApS ›

John Michael Maraganore

Via Hemab ApS ›

AI DEN-MAB LLC

Via Hemab ApS ›

DEEP TRACK BIOTECHNOLOGY MASTER FUND, LTD.

Via Hemab ApS ›

AVORO VENTURES FUND L.P.

Via Hemab ApS ›

RA Capital Nexus Fund II, L.P.

Via Hemab ApS ›

RA Capital Healthcare Fund, L.P.

Via Hemab ApS ›

HealthCap VIII L.P.

Via Hemab ApS ›

Reinaldo Miguel Diaz

Via RheumaLogics ApS ›

Demetrios Thomas Braddock

Via RheumaLogics ApS ›